Key result
Antiplatelet therapy counseling addresses primary prevention in an asymptomatic man with high CAD risk.
Why the study?
How should an asymptomatic man with cardiovascular risk factors be counseled about antiplatelet therapy?
Case Report (n=1)
How should an asymptomatic man with cardiovascular risk factors be counseled about antiplatelet therapy?
This case presentation highlights the clinical decision-making process for initiating antiplatelet therapy in primary prevention for a patient with multiple cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Supports individualized counseling on antiplatelet primary prevention; leaves open net-benefit questions pending randomized data.
ase presentation: An asymptomatic man (J.D.) is referred for a cardiovascular evaluation.He has a strong family history of coronary artery disease and has received more than 10 years of treatment for hypertension and dyslipidemia.Past medical history is significant for symptomatic degenerative joint disease.Medications include hydrochlorothiazide, lisinopril, atorvastatin, and celecoxib.How should he be counseled about antiplatelet therapy?
No takes yet. Share an insight, caveat, or question.
Bates et al. (2005) conducted a case report in Cardiovascular evaluation (n=1). Antiplatelet therapy was evaluated. Antiplatelet therapy counseling is discussed for an asymptomatic man with a strong family history of coronary artery disease, hypertension, and dyslipidemia.
Synapse has enriched 10 related papers. Consider them for comparative context: